In Vitro Study of the Effect of Gadolinium Contrast on Fibrocytes
Condition(s):Gadolinium ToxicityLast Updated:July 31, 2015Unknown status
Hide Studies Not Open or Pending
Condition(s):Gadolinium ToxicityLast Updated:July 31, 2015Unknown status
Condition(s):Focus: Long-term Retention of Gadolinium Contrast AgentLast Updated:March 2, 2020Completed
Condition(s):Pulmonary EmbolismLast Updated:February 17, 2020Withdrawn
Condition(s):Contrast Media AllergyLast Updated:September 28, 2016Unknown status
Condition(s):Non-Hodgkin’s LymphomaLast Updated:June 4, 2015Terminated
Condition(s):Brain MetastasesLast Updated:June 7, 2019Completed
Condition(s):Lung CancerLast Updated:July 24, 2014Terminated
Condition(s):Gadolinium; MultiHance; Dotarem; Magnetic Resonance Imaging; Gadolinium RetentionLast Updated:December 28, 2020Recruiting
Condition(s):Central Nervous System Neoplasm; Cranial Nerve DisorderLast Updated:December 2, 2020Recruiting
Condition(s):Heavy Metal ToxicityLast Updated:August 29, 2017Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.